Pfizer Partner BioNTech Confident Vaccine Effective Against UK Mutant COVID-19 Strain
Ugur Sahin, CEO of BioNTech SE (NASDAQ: BNTX) — the German partner of Pfizer Inc (NYSE: PFE) — expressed confidence that two companies’ jointly-developed vaccine is effective against a new mutation of COV
